Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-09T19:10:28.840Z Has data issue: false hasContentIssue false
  • English
  • Français

Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci

Published online by Cambridge University Press:  15 May 2009

W. Charles Huskins  and
Edward L. Kaplan
W. Charles Huskins
Affiliation:
Department of Pediatrics and the World Health Organization Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical school, Minneapolis, Minnesota
Edward L. Kaplan*
Affiliation:
Department of Pediatrics and the World Health Organization Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical school, Minneapolis, Minnesota
*
†Correspondence/reprint requests to: Edward L. Kaplan, Department of Pediatrics. Box 296 UMHC University of Minnesota Medical School. 420 Delaware St. S.E., Minneapolis. MX 55455.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It has been proposed that inhibitory substances produced by viridans streptococci colonizing the upper respiratory tract aid in cradication of established group A streptococcal colonization of that site. We studied the prevalence of inhibitory-substance producing strains of Streptococcus salivarius in throat cultures from three groups of children: 16 children with persistently positive throat cultures for group A streptococci despite receiving recommended therapeutic courses of antibiotics (group I). 26 children from whom group A streptococci were eradicated from the upper respirator tract by antibiotic therapy (group II). and 18 children who never harboured group A streptococci in their upper respiratory tract during the study period (group Ill). An vitro deferred antagonism method was employed to detect inhibitory substances: 5233 strains of S. salivarius were examined. Strains of S. salivarius producing inhibitory substances were isolated from 76−88% of the children in each group on at least one occasion.However, only a small percentage of subjects in each group harboured strains producing these substances in every throat culture. The mean total percentage of S. salivarius strains producing inhibitory substances was 21·8% in children in group 1·22.4 % in children in group II. and 16.4% in children in group III: these percentages were not statistically different (P > 0·1). In this study, we could not confirm a significant role for inhibitory substances produced by S. salivarius in the eradication of group A streptococci from the upper respiratory tract of colonized individuals.

Type
Special Article
Information
Epidemiology & Infection , Volume 102 , Issue 3 , June 1989 , pp. 401 - 412
Copyright
Copyright © Cambridge University Press 1989

References

REFERENCES

Brook, I. (1984). The role of beta-lactamase producing bacteria in the persistence of streptococcal tonsillar infection. Reviews of Infectious Disease 6, 601–607.Google Scholar
Committee On Prevention Of Rheumatic Fever And Bacterial Endocarditis Of The American Heart Association (1977). Prevention of rheumatic fever. Circulation 55, 1–4.Google Scholar
Crowe, C. C.Sanders, W. E. Jr. & Longley, S. (1973). Bacterial interference. II. Role of the normal flora in prevention of colonization by group A streptococci. Journal of lnfectious Disease 128, 527–532.Google Scholar
Dajani, A. S.. Tom, M. C. & Law, D. J. (1976). Viridins. bacteriocins of alpha-hemolytic streptococci Isolation, characterization, and partial purification. Antinocrobial Agents and Chemotherapy 9, 81–88.CrossRefGoogle ScholarPubMed
Dempster, R. P. & Tagg, J. R. (1982). The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.Archives of oral Biology 27, 151–157.Google Scholar
Facklam, R. R. (1977). Physiologie differentiation of viridous streptococci. Journal of Clinical Microbiology 15, 184–201.CrossRefGoogle Scholar
Gerasimov, A. V. (1968). Bacteriocinogenia in Str. viridans. Zhurnal Mikrobiologii. Epidemiologii. Immunobiolii 45, 28–32.Google Scholar
Grahn, E. & Holm, S. E. (1983). Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralblatt für Bakteriolgie. Microbiologie and Hygiene 256, 72–79.Google Scholar
Hardie, J. M. & Marsh, P.D. (1978). Streptococci and the human oral flora. In streptococci. (ed.. Skinner, F. A. and Quesnel, L. B.). pp. 147–206. London: Academic Press.Google ScholarPubMed
Kaplan, E. L., Couser, R. & Huwe, B. B. (1979). Significance of quantitative salivary cultures for group A streptococci and non-group A beta-hemolytic streptococci in patients with pharyngitis and in their family contacts. Pediatrics 64, 904–912.CrossRefGoogle Scholar
Kaplan, E. L.Gastanaduy, A. S. & Huwe, B. B. (1981). The role of the Cairier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. Journal of Laboratory and Clinical Medicine 98, 326–335.Google Scholar
Malke, H., Starke, R., Jacob, H. E. & Köhler, W. (1974). Bacteriocine-like activity of group A streptococci due to the production of peroxide. Journal of Medical Microbiology 7, 367–374.CrossRefGoogle Scholar
Sanders, E. (1969). Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci. Journal of Infectious Diseas 120, 698–707.Google Scholar
Sanders, C. C., Nelson, G. E. & Sanders, W. E. Jr., (1977). Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci. Infection and Immunity 16, 599–603.Google Scholar
Sanders, C. C. & Sanders, W. E. Jr (1982). Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. Journal of Infectious Disease 46, 683–690.CrossRefGoogle Scholar
Sanders, C. C., Sanders, W. E. Jr & Harrowe, D. J. (1976). Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infection and Immunity 3, 808–812.CrossRefGoogle Scholar
Smith, T. D., Huskins, W. C., Kim, K. S. & Kaplan, E. L. (1988). Efficacy of a beta-lactamase resistant penicillin and the role of penicillin tolerance in eradicating group A streptococci from the upper respiratory tract after penicillin treatment failures during an outbreak of streptococcal pharyngitis. Journal of Pediatrics 110, 777–782.Google Scholar
Tagg, J. R., Dajani, A. S. & Wannamaker, L. W. (1976). Bacteriocins of gram-positive bacteria. Bacteriological Reviews 40, 722–756.CrossRefGoogle ScholarPubMed
Tagg, J. R., Pybus, V., Phillips, L. V. & Fiddes, T. M. (1983). Application of inhibition typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Archives of Oral Biology 28, 911–915.Google Scholar
Tagg, J. R. & Wong, H. K. (1983). Inhibitor production by group G streptococci of human and of animal origin. Journal of Medical Microbiology 16, 409–415.Google Scholar